Open AccessGood outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia
Author(s) -
B. Granel,
P. Rossi,
F. Bernard,
Isabelle Dettori,
Régis T. Costello,
A.-L. Demoux,
D. Bagnères,
P. Lafforgue,
Y. Francès
Publication year - 2009
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr.09.2008.0857
Subject(s) - rituximab , medicine , mixed connective tissue disease , immunology , cold agglutinin disease , lymphoproliferative disorders , autoimmune disease , rheumatology , autoimmune hemolytic anemia , antibody , lymphoma
Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.